SCHEMBL2069777

SCHEMBL2069777

[CH2]c1ccc(C(Cl)(Cl)Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.50
▸ MAPK1 P28482 1/20 0.31
▸ HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9816151 0.83 TSHR (0.67) TSHRMAPK1HIF1A
SCHEMBL545084 0.83 TSHR (0.67) TSHRMAPK1HIF1A
SCHEMBL18243502 0.77 TSHR (0.33) TSHRMAPK1HIF1A
SCHEMBL5250772 0.75 TSHR (0.43) TSHR
SCHEMBL7949296 0.73 TSHR (0.56) TSHRMAPK1HIF1A
SCHEMBL1538637 0.73 TSHR (0.56) TSHRMAPK1HIF1A
SCHEMBL18243581 0.73 TSHR (0.31) TSHRMAPK1HIF1A
SCHEMBL11231213 0.71 TSHR (0.53) TSHRMAPK1HIF1A
SCHEMBL196830 0.71 TSHR (0.57) TSHRMAPK1HIF1A
SCHEMBL11601223 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116199571-A Method for controlling content of organic carboxylic acid in synthesis process of benzophenone photoinitiator 宜都市友源实业有限公司 2023-06-02 — — CN claimed
CN-116199571-A Method for controlling content of organic carboxylic acid in synthesis process of benzophenone photoinitiator 宜都市友源实业有限公司 2023-06-02 — — CN disclosed
CN-110563605-B Intermediate for preparing eptazocine hydrobromide and preparation method thereof 上海医药工业研究院 2021-10-08 — — CN disclosed
CN-110563605-A Intermediate for preparing eptazocine hydrobromide and preparation method thereof 上海医药工业研究院 2019-12-13 — — CN disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 — — US disclosed
CN-105764885-B The production method of acid and free-radical generating agent and acid and free radical 富士胶片和光纯药株式会社 2018-11-09 — — CN disclosed
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2016-11-24 — — US disclosed
CN-105764885-A Acid- and radical-generating agent and method for generating acid and radical 和光纯药工业株式会社 2016-07-13 — — CN disclosed
EP-2095875-B1 Homogeneous asymmetric hydrogenation catalyst TAKASAGO PERFUMERY CO LTD (JP) 2014-10-01 — — EP disclosed
EP-1911516-B1 HOMOGENEOUS ASYMMETRIC HYDROGENATION PROCESS TAKASAGO PERFUMERY CO LTD (JP) 2014-05-14 — — EP disclosed
US-4876275-A 3,4-dihydro-2H-pyrans useful as pesticides BASF AKTIENGESELLSCHAFT (DE) 1989-10-24 — — US disclosed
EP-0328955-A2 Process for the preparation of imidazole-2-carboxylic acids BASF Aktiengesellschaft (DE) 1989-08-23 — — EP disclosed
EP-0320733-A2 2-tert.-butyl-5-isoxazolyl methylthio-3(2H)-pyridazin-3-one derivatives BASF Aktiengesellschaft (DE) 1989-06-21 — — EP disclosed
US-4822780-A CALCIUM ANTAGONIST, ANTIINFLAMMATORY AGENT OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-04-18 — — US disclosed
EP-0287959-A2 p-Phenoxy--phenoxymethyl substituted five membered heteroaromatics BASF Aktiengesellschaft (DE) 1988-10-26 — — EP disclosed
EP-0285936-A1 3,4-Dihydro-2H-pyrans BASF Aktiengesellschaft (DE) 1988-10-12 — — EP disclosed
EP-0273444-A2 Use of carboxamide compounds for the preparation of a medicament for treating hyperlipidemia OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-07-06 — — EP disclosed
US-4273573-A Agents for regulating plant growth using 2-thiazolone-5-carboxylic acid compounds BAYER AKTIENGESELLSCHAFT (DE) 1981-06-16 — — US disclosed
EP-0005204-A2 Plant growth regulating compositions containing 2-thiazolon-5-carboxylic acid derivatives, their preparation and their application BAYER AG (DE) 1979-11-14 — — EP disclosed
US-4111933-A PROTECTION OF FUNCTIONAL GROUPS DURING REACTION AND THEIR SUBSEQUENT RESTORATION BAYER AKTIENGESELLSCHAFT (DE) 1978-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 TSHR 648/4885MAPK1 1089/4885HIF1A 226/4885
US-20160342084-A1 ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL CBR1, HAO2, CBR3 TSHR 648/4885MAPK1 1089/4885HIF1A 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback